Elucid announced the launch of its PlaqueIQ image analysis software for the quantification and classification of plaque ...

The Centers for Medicare & Medicaid Services (CMS) has released the final National Coverage Determination (NCD) on renal de ...

HistoSonics, Inc., developer of the Edison histotripsy system and histotripsy therapy platform, announced the closing of $250 m ...

Thrombolex, Inc. announced findings from a prespecified interim analysis from the first 50 patients in the postmarket RAPID-PE ...

Gore & Associates announced FDA approval of a 6- to 10-mm diameter range for the Viatorr TIPS—transjugular intrahepat ...

Polyembo announced it has closed a new round of funding led by a multinational strategic investor to advance innovative pr ...

Medtronic announced that long-term results from its final report of the SPYRAL HTN-ON MED trial showed that patients treated wi ...

Penumbra, Inc. announced that the results of the STORM-PE randomized controlled trial showed that mechanical thrombectomy using ...

The PERT Consortium announced the launch of The PRISM Program, an initiative to expand access, collaboration, and excellence ...

Techsomed Ltd., an Israel-based developer of medical artificial intelligence–powered software for image-guided therapy, a ...

Qure.ai announced FDA 510(k) clearance for its qER-CTA artificial intelligence (AI) solution, which is designed to analyze CTA ...

Access Vascular, Inc. announced that the FDA cleared a new indication for its single-lumen Mimix HydroMid midline catheter and ...